News
Stem cell agency indirectly boosted by national industry group
A clinical researcher with a multi-pipette arrangement of cancer stem cells. (Photo: Science Photo, via Shutterstock)One of the nation’s leading regenerative medicine industry groups is touting multi-billion dollar savings that may be achieved with the type of stem cell and gene therapies that are being developed with cash from California’s financially beleaguered stem cell program.